Sunesis Pharmaceuticals Inc.

(SNSS) Trade

By |

Profile

Sunesis Pharmaceuticals Inc is a US-based biopharmaceutical company. It focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers. The product portfolio of the company includes QINPREZO (vosaroxin) is an anticancer quinolone derivative for the treatment of acute myeloid leukemia (AML). The company's other kinase inhibitor pipeline includes TAK-580, SNS-062, and SNS-229. Further, the firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The firm derives substantially the majority of revenue from license and collaboration agreements.

Contact Information

Website: www.sunesis.com
Email: bjerkholt@sunesis.com
Main Phone: +1 650 266-3500
Address: 395 Oyster Point Boulevard
Address 2: Suite 400
State: CA
City / Town: South San Francisco
Country: USA
Postal Code: 94080

Issuer Information

Exchange: NSC
CEO: Dayton Misfeldt
Employees: 34
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.42 $ -0.0401 (-8.74%)
Last Price 0.42 Change $ -0.0401 Change % -8.74 Tick N/A
Bid 0.42 Bid Size 600.00 Ask 0.42 Ask Size 77,100.00
Open 0.47 High 0.47 Low 0.40 Prev Close 0.46
Last Trade Volume 426,803 52 Wk Hi 7.69 52 Wk Low 0.40
Market Cap 15.7 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 37,421,509.00 EPS (TTM) -0.74 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 4
Number of Buys 0 4
Number of Sells 0 0
Net Activity 0 600000
Last 10 Buys Shares
Dayton Misfeldt 1,000
Dayton Misfeldt 1,000
Dayton Misfeldt 1,000
Dayton Misfeldt 1,000
Geoffrey M. Parker 1,000
Geoffrey M. Parker 1,000
Geoffrey M. Parker 1,000
Geoffrey M. Parker 1,000
Geoffrey M. Parker 1,000
Geoffrey M. Parker 1,000
Last 10 Sell Shares
Eric H. Bjerkholt 1,000
Eric H. Bjerkholt 1,000
Steven B. Ketchum 1,000
Daniel N. Swisher 1,000
Daniel N. Swisher 1,000
Steven B. Ketchum 1,000
Dayton Misfeldt 1,000
Dayton Misfeldt 1,000
Dayton Misfeldt 1,000
Dayton Misfeldt 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 8 8 8 8
Low Target Price Estimate 4 4 4 4
Mean Target Price Estimate 6.33 6.33 6.33 6.33
Standard Deviation 2.08 2.08 2.08 2.08
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.67 1.67 1.67 1.67